Anthony Rodriguez

Anthony Rodriguez is a PhD candidate in bioengineering at the the University of Washington, and the president emeritus of the Student Engineering Business Association at UW. He is also co-founder of nPostBio.

Recent posts

No Time for the Academic Entrepreneur
The recurring question I hear from so many people in business is: “Why aren’t more startups generated by the university system?” It’s not an easy question, certainly not one to be... Read more »
It Takes a Village to Raise an Entrepreneur: Cultivating the Emerging Seattle Talent Pool
It can be argued that among talent, cash and technology, no factor is more critical to a start up than talent. The talent drives innovation, attracts the venture capital and makes... Read more »
UW Business Plan Competition Kick-Starts Companies to Action
The University of Washington Business Plan Competition hosted by the Center for Innovation and Entrepreneurship (CIE) came to a close Thursday night, handing out $60,000 in prize money to an impressive... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences San Diego: Special Report
Learn what's fueling San Diego's biotech investment and partnership opportunities

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

AbCellera Raises $105M to Advance Antibody Discovery Operations

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Morphic Appoints ArQule’s Schegerin Chief Financial, Operating Officer

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Anthony Rodriguez

Recent posts

No Time for the Academic Entrepreneur

It Takes a Village to Raise an Entrepreneur: Cultivating the Emerging Seattle Talent Pool

UW Business Plan Competition Kick-Starts Companies to Action

Underwriters and Partners

Xcelerating Life Sciences San Diego: Special Report

Robert Langer reveals secrets to early-stage biotech success

Potency Assay Development for Cell and Gene Therapy Products

Xconomy on Demand

We offer a number of ways to subscribe for free!